Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

被引:996
作者
Goulder, PJR
Phillips, RE
Colbert, RA
McAdam, S
Ogg, G
Nowak, MA
Giangrande, P
Luzzi, G
Morgan, B
Edwards, A
McMichael, AJ
RowlandJones, S
机构
[1] UNIV OXFORD,INST MOL MED,OXFORD OX3 9DU,ENGLAND
[2] CHILDRENS HOSP,MED CTR,WILLIAM S ROWE DIV RHEUMATOL,CINCINNATI,OH 45229
[3] UNIV OXFORD,DEPT ZOOL,OXFORD OX1 3PS,ENGLAND
[4] CHURCHILL HOSP,OXFORD HAEMOPHILIA CTR,OXFORD OX3 7LJ,ENGLAND
[5] WYCOMBE GEN HOSP,S BUCKINGHAMSHIRE NHS TRUST,HIGH WYCOMBE HP11 2TT,BUCKS,ENGLAND
[6] RADCLIFFE INFIRM,OXFORD OX2 6HE,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1038/nm0297-212
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The precise role played by HIV-specific cytotoxic T lymphocytes (CTL) in HIV infection remains controversial. Despite strong CTL responses being generated during the asymptomatic phase, the virus persists and AIDS ultimately develops. It has been argued that the virus is so variable, and the virus turnover so great that escape from CTL recognition would occur continually, but so far there is limited evidence for CTL escape. The opposing argument is that evidence for CTL escape is present but hard to find because multiple anti-HIV immune responses are acting simultaneously during the asymptomatic phase of infection. We describe six donors who make a strong CTL response to an immunodominant HLA-B27-restricted epitope. In the two donors who progressed to AIDS, CTL escape to fixation by the same mutation was observed, but only after 9-12 years of epitope stability. CTL escape may play an important role in the pathogenesis of HIV infection.
引用
收藏
页码:212 / 217
页数:6
相关论文
共 34 条
  • [1] WHY CANT CYTOTOXIC T-CELLS HANDLE HIV
    BEVAN, MJ
    BRACIALE, TJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (13) : 5765 - 5767
  • [2] VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    BORROW, P
    LEWICKI, H
    HAHN, BH
    SHAW, GM
    OLDSTONE, MBA
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6103 - 6110
  • [3] QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE
    CARMICHAEL, A
    JIN, X
    SISSONS, P
    BORYSIEWICZ, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 249 - 256
  • [4] THE BINDING-AFFINITY AND DISSOCIATION RATES OF PEPTIDES FOR CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES
    CERUNDOLO, V
    ELLIOTT, T
    ELVIN, J
    BASTIN, J
    RAMMENSEE, HG
    TOWNSEND, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (09) : 2069 - 2075
  • [5] IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS
    COCCHI, F
    DEVICO, AL
    GARZINODEMO, A
    ARYA, SK
    GALLO, RC
    LUSSO, P
    [J]. SCIENCE, 1995, 270 (5243) : 1811 - 1815
  • [6] DIFFERENCES IN PEPTIDE PRESENTATION BETWEEN B27 SUBTYPES - THE IMPORTANCE OF THE P1 SIDE-CHAIN IN MAINTAINING HIGH-AFFINITY PEPTIDE BINDING TO B-ASTERISK-2703
    COLBERT, RA
    ROWLANDJONES, SL
    MCMICHAEL, AJ
    FRELINGER, JA
    [J]. IMMUNITY, 1994, 1 (02) : 121 - 130
  • [7] IMPAIRED CYTOTOXIC T-LYMPHOCYTE RECOGNITION DUE TO GENETIC VARIATIONS IN THE MAIN IMMUNOGENIC REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS-1 NEF PROTEIN
    COUILLIN, I
    CULMANNPENCIOLELLI, B
    GOMARD, E
    CHOPPIN, J
    LEVY, JP
    GUILLET, JG
    SARAGOSTI, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) : 1129 - 1134
  • [8] GOTCH F, 1987, THESIS U OXFORD
  • [9] GOULDER PJR, IN PRESS AIDS
  • [10] Harrer T, 1996, J IMMUNOL, V156, P2616